new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)





Similar
Filing Names

Moderna Therapeutics Inc
Moderna Therapeutics
  

Moderna Therapeutics patents

Recent patent applications related to Moderna Therapeutics. Moderna Therapeutics is listed as an Agent/Assignee. Note: Moderna Therapeutics may have other listings under different names/spellings. We're not affiliated with Moderna Therapeutics, we're just tracking patents.

ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "M" | Moderna Therapeutics-related inventors




Date Moderna Therapeutics patents (updated weekly) - BOOKMARK this page
01/09/14Modified polynucleotides for the production of proteins associated with human disease
10/03/13Modified polynucleotides for the production of secreted proteins
10/03/13Modified polynucleotides for the production of biologics and proteins associated with human disease
09/26/13Formulation and delivery of plga microspheres
09/26/13Modified polynucleotides for the production of g-csf
09/19/13Formulation and delivery of plga microspheres
09/19/13Formulation and delivery of plga microspheres
09/19/13Method of producing antibodies
09/19/13Modified polynucleotides for the production of factor ix
09/19/13Method for producing a protein of interest in a primate
09/19/13Dlin-kc2-dma lipid nanoparticle delivery of modified polynucleotides
09/19/13Method of producing a protein of interest
09/19/13Dlin-mc3-dma lipid nanoparticle delivery of modified polynucleotides
09/12/13Method for increasing the production of a protein of interest
09/12/13Method for producing a protein of interest at the site of a clot
09/12/13Multi-site administration
09/12/13Split dose administration
06/27/13Methods of increasing the viability or longevity of an organ or organ explant
06/20/13Modified nucleoside, nucleotide, and nucleic acid compositions
05/16/13Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
05/09/13Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
10/04/12Delivery and formulation of engineered nucleic acids
03/09/17Engineered nucleic acids and methods of use thereof
03/02/17Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
01/05/17Polynucleotides for the in vivo production of antibodies
12/29/16Modified polynucleotides for the production of secreted proteins
12/08/16Modified nucleic acid molecules and uses thereof
12/08/16Modified nucleic acid molecules and uses thereof
12/08/16Modified nucleic acid molecules and uses thereof
12/08/16Modified nucleic acid molecules and uses thereof
12/01/16Modified nucleic acid molecules and uses thereof
11/17/16Nucleic acid vaccines
11/03/16Nucleic acid vaccines
10/20/16Modified nucleic acid molecules and uses thereof
10/06/16Modified polynucleotides for the production of membrane proteins
09/22/16Engineered nucleic acids and methods of use thereof
09/15/16Polynucleotide molecules and uses thereof
09/15/16Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
09/08/16Engineered nucleic acids and methods of use thereof for non-human vertebrates
09/08/16Modified nucleic acids, and acute care uses thereof
08/25/16Compositions and methods for tolerizing cellular systems
08/25/16Polynucleotide compositions containing amino acids
08/25/16Polynucleotides encoding low density lipoprotein receptor
08/25/16Polynucleotides encoding immune modulating polypeptides
08/18/16Polynucleotide molecules and uses thereof
08/18/16Alternative nucleic acid molecules containing reduced uracil content and uses thereof
07/21/16Methods of increasing the viability or longevity of an organ or organ explant
07/14/16Modified polynucleotides for the production of proteins associated with human disease
07/07/16Circular polynucleotides
07/07/16Modified nucleoside, nucleotide, and nucleic acid compositions
07/07/16Circular polynucleotides
07/07/16Chimeric polynucleotides
06/09/16Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
06/02/16Modified polynucleotides for the production of proteins
06/02/16Modified polynucleotides for the production of oncology-related proteins and peptides
05/19/16Compositions and methods of altering cholesterol levels
04/28/16Modified polynucleotides for the production of nuclear proteins
03/17/16Modified polynucleotides for the production of biologics and proteins associated with human disease
02/11/16Formulation and delivery of modified nucleoside, nucleotide, and nucleic acid compositions
02/04/16Characterization of mrna molecules
01/28/16Diagnosis and treatment of fibrosis
01/28/16Heterologous untranslated regions for mrna
01/28/16Ribonucleic acid purification
01/28/16Ion exchange purification of mrna
01/28/16Engineered nucleic acids and methods of use thereof
Patent Packs
01/28/16Long-lived polynucleotide molecules
01/28/16Removal of dna fragments in mrna production process
01/28/16Manufacturing methods for production of rna transcripts
01/21/16Analysis of mrna heterogeneity and stability
12/31/15In vivo production of proteins
12/24/15Modified polynucleotides for the production of secreted proteins
11/05/15Modified polynucleotides for altering cell phenotype
10/29/15Modified nucleic acid molecules and uses thereof
09/03/15Modified polynucleotides for the production of nuclear proteins
07/30/15Enzymes and polymerases for the synthesis of rna
06/18/15Modified polynucleotides for the production of cosmetic proteins and peptides
06/18/15Alternative nucleic acid molecules and uses thereof
05/21/15Engineered nucleic acids and methods of use thereof
04/23/15In vivo production of proteins
03/26/15Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
Patent Packs
03/05/15Modified polynucleotides
03/05/15Modified polynucleotides for the production of proteins
03/05/15Engineered nucleic acids and methods of use thereof
02/26/15Engineered nucleic acids and methods of use thereof
02/19/15Modified polynucleotides for the treatment of otic diseases and conditions
02/19/15Methods of increasing the viability or longevity of an organ or organ explant
02/12/15Modified polynucleotides encoding caspase 3
01/29/15Methods and compositions for targeting agents into and across the blood-brain barrier
01/15/15Delivery and formulation of engineered nucleic acids
01/01/15Compositions and methods of altering cholesterol levels
09/18/14Compositions and methods of altering cholesterol levels
09/18/14Modified polynucleotides encoding udp glucuronosyltransferase 1 family, polypeptide a1
09/11/14Modified polynucleotides encoding cytotoxic t-lymphocyte-associated protein 4
09/11/14Modified polynucleotides encoding programmed cell death 1
09/04/14Modified polynucleotides for treating protein deficiency
08/28/14Engineered nucleic acids and methods of use thereof
08/07/14Modified polynucleotides for treating galactosylceramidase protein deficiency
07/24/14Engineered nucleic acids and methods of use thereof for non-human vertebrates
07/24/14Modified polynucleotides for treating arylsulfatase a protein deficiency
07/24/14Signal-sensor polynucleotides
07/17/14Modified polynucleotides encoding basic helix-loop-helix family, member e41
07/17/14Signal-sensor polynucleotides for the alteration of cellular phenotypes
07/17/14Modified polynucleotides for the production of proteins associated with blood and lymphatic disorders
07/17/14Modified polynucleotides for treating galactosidase, alpha protein deficiency
07/17/14Modified polynucleotides for treating carboxypeptidase n, polypeptide 1 protein deficiency
07/10/14Modified polynucleotides encoding v-myc avian myelocytomatosis viral oncogene homolog
07/10/14Modified polynucleotides for treating protein deficiency
07/03/14Modified polynucleotides encoding cited4
06/26/14Modified polynucleotides for treating dolichyl-phosphate (udp-n-acetylglucosamine) n-acetylglucosaminephosphotransferase 1 (glcnac-1-p transferase) protein deficiency
06/19/14Modified polynucleotides encoding cd28 molecule
Social Network Patent Pack
06/12/14Modified polynucleotides encoding aryl hydrocarbon receptor nuclear translocator
06/05/14Modified polynucleotides for treating argininosuccinate synthase 1 protein deficiency
06/05/14Modified polynucleotides for treating cystic fibrosis
06/05/14Modified polynucleotides for treating lipase a, lysosomal acid, cholesterol esterase protein deficiency
05/29/14Modified polynucleotides for the production of proteins associated with blood and lymphatic disorders
05/29/14Terminally modified rna
05/29/14Modified polynucleotides for treating protein deficiency
05/22/14Modified polynucleotides encoding septin-4
05/22/14Modified polynucleotides encoding siah e3 ubiquitin protein ligase 1
04/24/14Modified polynucleotides encoding caspase 6
Patent Packs
04/24/14Modified polynucleotides encoding granulysin
04/17/14Modified polynucleotides encoding aquaporin-5
04/17/14Modified polynucleotides encoding copper metabolism (murr1) domain containing 1
04/17/14Modified polynucleotides encoding hepatitis a virus cellular receptor 2
04/17/14Modified polynucleotides encoding apoptosis inducing factor 1
08/08/13Modified nucleosides, nucleotides, and nucleic acids, and uses thereof







ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Moderna Therapeutics in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Moderna Therapeutics with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';